- Home
- PTHL vs RDZN Comparison
PTHL vs RDZN Comparison
Compare PTHL & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTHL
- RDZN
- Stock Information
- Founded
- PTHL 1998
- RDZN 2015
- Country
- PTHL China
- RDZN United States
- Employees
- PTHL N/A
- RDZN N/A
- Industry
- PTHL
- RDZN Blank Checks
- Sector
- PTHL
- RDZN Finance
- Exchange
- PTHL Nasdaq
- RDZN Nasdaq
- Market Cap
- PTHL 85.4M
- RDZN 79.4M
- IPO Year
- PTHL 2024
- RDZN N/A
- Fundamental
- Price
- PTHL $18.50
- RDZN $0.99
- Analyst Decision
- PTHL
- RDZN Strong Buy
- Analyst Count
- PTHL 0
- RDZN 2
- Target Price
- PTHL N/A
- RDZN $5.00
- AVG Volume (30 Days)
- PTHL 1.0M
- RDZN 646.9K
- Earning Date
- PTHL 02-11-2025
- RDZN 06-26-2025
- Dividend Yield
- PTHL N/A
- RDZN N/A
- EPS Growth
- PTHL N/A
- RDZN N/A
- EPS
- PTHL N/A
- RDZN N/A
- Revenue
- PTHL $448,196.00
- RDZN $44,296,098.00
- Revenue This Year
- PTHL N/A
- RDZN $4.52
- Revenue Next Year
- PTHL N/A
- RDZN $53.72
- P/E Ratio
- PTHL N/A
- RDZN N/A
- Revenue Growth
- PTHL N/A
- RDZN N/A
- 52 Week Low
- PTHL $1.32
- RDZN $0.68
- 52 Week High
- PTHL $22.34
- RDZN $3.28
- Technical
- Relative Strength Index (RSI)
- PTHL N/A
- RDZN 48.13
- Support Level
- PTHL N/A
- RDZN $1.00
- Resistance Level
- PTHL N/A
- RDZN $1.22
- Average True Range (ATR)
- PTHL 0.00
- RDZN 0.12
- MACD
- PTHL 0.00
- RDZN -0.01
- Stochastic Oscillator
- PTHL 0.00
- RDZN 29.21
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.